1. Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up. (7th July 2015) Authors: Ludwig, Heinz; Greil, Richard; Masszi, Tamas; Spicka, Ivan; Shpilberg, Ofer; Hajek, Roman; Dmoszynska, Anna; Paiva, Bruno; Vidriales, María‐Belén; Esteves, Graca; Stoppa, Anne Marie; Robinson, Don; Chaturvedi, Shalini; Ataman, Ozlem; Enny, Christopher; Feng, Huaibao; van de Velde, Helgi; Viterbo,... Journal: British journal of haematology Issue: Volume 171:Number 3(2015:Nov.) Page Start: 344 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Bosutinib efficacy and safety in chronic phase chronic myeloid leukemia after imatinib resistance or intolerance: Minimum 24‐month follow‐up. Issue 7 (28th April 2014) Authors: Gambacorti‐Passerini, Carlo; Brümmendorf, Tim H.; Kim, Dong‐Wook; Turkina, Anna G.; Masszi, Tamas; Assouline, Sarit; Durrant, Simon; Kantarjian, Hagop M.; Khoury, H. Jean; Zaritskey, Andrey; Shen, Zhi‐Xiang; Jin, Jie; Vellenga, Edo; Pasquini, Ricardo; Mathews, Vikram; Cervantes, Francisco; Besson... Journal: American journal of hematology Issue: Volume 89:Issue 7(2014:Jul.) Page Start: 732 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Brentuximab vedotin as consolidation therapy after autologous stem-cell transplantation in patients with Hodgkin's lymphoma at risk of relapse or progression (AETHERA): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 9980 (9th May 2015) Authors: Moskowitz, Craig H; Nademanee, Auayporn; Masszi, Tamas; Agura, Edward; Holowiecki, Jerzy; Abidi, Muneer H; Chen, Andy I; Stiff, Patrick; Gianni, Alessandro M; Carella, Angelo; Osmanov, Dzhelil; Bachanova, Veronika; Sweetenham, John; Sureda, Anna; Huebner, Dirk; Sievers, Eric L; Chi, Andy; Larsen,... Journal: Lancet Issue: Volume 385:Issue 9980(2015) Page Start: 1853 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Changes in quality of life and disease‐related symptoms in patients with polycythemia vera receiving ruxolitinib or standard therapy. (3rd January 2016) Authors: Mesa, Ruben; Verstovsek, Srdan; Kiladjian, Jean‐Jacques; Griesshammer, Martin; Masszi, Tamas; Durrant, Simon; Passamonti, Francesco; Harrison, Claire N.; Pane, Fabrizio; Zachee, Pierre; Zhen, Huiling; Jones, Mark M.; Parasuraman, Shreekant; Li, Jingjin; Côté, Isabelle; Habr, Dany; Vannucchi, Ales... Journal: European journal of haematology Issue: Volume 97:Number 2(2016:Aug.) Page Start: 192 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Comprehensive haematological control with ruxolitinib in patients with polycythaemia vera resistant to or intolerant of hydroxycarbamide. (17th May 2017) Authors: Harrison, Claire N.; Griesshammer, Martin; Miller, Carole; Masszi, Tamas; Passamonti, Francesco; Zachee, Pierre; Durrant, Simon; Pane, Fabrizio; Guglielmelli, Paola; Verstovsek, Srdan; Jones, Mark M.; Hunter, Deborah S.; Sun, William; Li, Jingjin; Khan, Mahmudul; Habr, Dany; Kiladjian, Jean‐Jacques Journal: British journal of haematology Issue: Volume 182:Number 2(2018) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Health‐related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial. (8th February 2021) Authors: Hungria, Vania; Beksac, Meral; Weisel, Katja C.; Nooka, Ajay K.; Masszi, Tamas; Spicka, Ivan; Munder, Markus; Mateos, María‐Victoria; Mark, Tomer M.; Qi, Ming; Qin, Xiang; Fastenau, John; Spencer, Andrew; Sonneveld, Pieter; Garvin, Wendy; Renaud, Thomas; Gries, Katharine S. Journal: British journal of haematology Issue: Volume 193:Number 3(2021) Page Start: 561 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. High dose chemotherapy and autologous stem cell transplantation in nodular lymphocyte‐predominant Hodgkin lymphoma: A retrospective study by the European society for blood and marrow transplantation‐lymphoma working party. Issue 1 (9th November 2017) Authors: Akhtar, Saad; Montoto, Silvia; Boumendil, Ariane; Finel, Herve; Masszi, Tamas; Jindra, Pavel; Nemet, Damir; Fuhrmann, Stephan; Beguin, Yves; Castagna, Luca; Ferrara, Felicetto; Capria, Saveria; Malladi, Ram; Moraleda, Jose Maria; Bloor, Adrian; Ghesquières, Hervé; Meissner, Julia; Sureda, Anna; D... Journal: American journal of hematology Issue: Volume 93:Issue 1(2018:Jan.) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Impact of venetoclax monotherapy on the quality of life of patients with relapsed or refractory chronic lymphocytic leukemia: results from the phase 3b VENICE II trial. Issue 2 (28th January 2022) Authors: Cochrane, Tara; Enrico, Alicia; Gomez-Almaguer, David; Hadjiev, Evgueniy; Lech-Maranda, Ewa; Masszi, Tamas; Nikitin, Eugene; Robak, Tadeusz; Weinkove, Robert; Wu, Shang-Ju; Sail, Kavita R.; Pesko, John; Pai, Madhavi; Komlosi, Viktor; Anderson, Mary Ann Journal: Leukemia & lymphoma Issue: Volume 63:Issue 2(2022) Page Start: 304 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial. Issue 10292 (19th June 2021) Authors: Moreau, Philippe; Dimopoulos, Meletios-Athanasios; Mikhael, Joseph; Yong, Kwee; Capra, Marcelo; Facon, Thierry; Hajek, Roman; Špička, Ivan; Baker, Ross; Kim, Kihyun; Martinez, Gracia; Min, Chang-Ki; Pour, Ludek; Leleu, Xavier; Oriol, Albert; Koh, Youngil; Suzuki, Kenshi; Risse, Marie-Laure; Asset... Journal: Lancet Issue: Volume 397:Issue 10292(2021) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Long-term efficacy and safety of ruxolitinib versus best available therapy in polycythaemia vera (RESPONSE): 5-year follow up of a phase 3 study. Issue 3 (March 2020) Authors: Kiladjian, Jean-Jacques; Zachee, Pierre; Hino, Masayuki; Pane, Fabrizio; Masszi, Tamas; Harrison, Claire N; Mesa, Ruben; Miller, Carole B; Passamonti, Francesco; Durrant, Simon; Griesshammer, Martin; Kirito, Keita; Besses, Carlos; Moiraghi, Beatriz; Rumi, Elisa; Rosti, Vittorio; Blau, Igor Wolfga... Journal: Lancet Issue: Volume 7:Issue 3(2020) Page Start: e226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗